Which ETFs hold CSL Ltd (CSL)?
Australian biotech making blood plasma therapies, vaccines and kidney treatments for global markets.
38 Australian ETFs hold CSL Ltd, a Health Care company from Australia. SYI has the biggest weighting at 13.04%. Across these funds, Australian ETF investors own about $3.0bn of CSL Ltd.
The ETFs with the most CSL Ltd
All 38 ETFs that hold CSL Ltd, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell CSL Ltd.
Common questions
Which ETF has the most CSL Ltd?
SYI (State Street SPDR MSCI Australia Select High Dividend Yield ETF) has the highest weighting, with 13.04% of the fund in CSL Ltd.
What is the cheapest ETF that holds CSL Ltd?
Of the ETFs where CSL Ltd is at least 1% of the fund, A300 has the lowest fee at 0.03% a year, with 3.63% in CSL Ltd.
How much CSL Ltd do I own with $10,000 in VAS?
About $320. VAS is the largest ETF that holds CSL Ltd, and CSL Ltd makes up 3.20% of it.
How many Australian ETFs hold CSL Ltd?
38 ETFs listed on the ASX or TMX Australia hold CSL Ltd, based on issuers' published holdings.